| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap |
RELAX, ACTRN12625001347459: The Relax Study: investigation of adjuvant Botox injection in the surgical repair of complicated perianal fistula disease |
|
|
| Not yet recruiting | N/A | 20 | | | Queen Elzabeth II Jubilee Hospital | Perianal Fistula | | | | |
ACTRN12624000500550: Hiprex versus standard management for preventing urinary tract infections post intravesical botox injection for overactive bladder: A randomised controlled trial |
|
|
| Not yet recruiting | N/A | 118 | | | Mercy Womens Hospital, Mercy Womens Hospital | urinary tract infection | | | | |
NCT00250952: Study to Determine If the Volume Used to Dilute BOTOX Cosmetic™ for Injection Affects Its Overall Effect and Duration. |
|
|
| Completed | N/A | 20 | US, Canada | Botox Cosmetic™ | Carruthers Dermatology Centre, Allergan | Skin Wrinkling | | 06/05 | | |
| Completed | N/A | 25 | RoW | Botulinum Toxin Type A, BOTOX (Allergan), myofunctional therapy | University of Sao Paulo General Hospital | Facial Paralysis | 12/05 | 12/06 | | |
NCT00282958: The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain |
|
|
| Completed | N/A | | US | Botulinum Toxin type a (Botox) | Palo Alto Veterans Institute for Research, Allergan | Subacute Cervical Pain, Subacute Upper Back Pain | | 07/06 | | |
NCT00395616: Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow |
|
|
| Unknown status | N/A | 40 | RoW | Botox (drug) | E-DA Hospital | Type A Botulinum Toxin, Tennis Elbow | | | | |
NCT00628472: Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort |
|
|
| Completed | N/A | 21 | US | botulinum type a, Botox | Henry Ford Health System | Pain | 05/07 | 05/07 | | |
NCT00199589: Treatment of Spastic Equinovarus Foot After Stroke |
|
|
| Completed | N/A | 46 | Europe | Botulinic toxin (Botox) | University Hospital, Limoges, Allergan | Spastic Equinovarus | | 12/07 | | |
NCT00435682 / 2006-001251-35: To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects |
|
|
| Completed | N/A | | Europe | Botox (Allergan Inc., US) | Aalborg University, Aalborg University Hospital | Healthy | 01/08 | 01/08 | | |
NCT00178191: Randomized Trial for Botox Urinary Incontinence |
|
|
| Completed | N/A | 28 | US | Bladder diary, Questionnaires, Urodynamics, Pad weight | University of Rochester, National Institutes of Health (NIH), National Institute on Aging (NIA) | Urinary Incontinence | 07/08 | 07/08 | | |
NCT00372970: Placebo Controlled Trial of Botulinum Toxin for Gastroparesis |
|
|
| Completed | N/A | 32 | US | Botulinum toxin A, Botox into pylorus, Placebo, saline injection into pylorus | Temple University, American College of Gastroenterology | Gastroparesis | 12/08 | 12/08 | | |
NCT00651339: The Effect of Botox Injection on Postural Stability of Cerebral Palsy (CP) Children |
|
|
| Terminated | N/A | 20 | RoW | botox | Soroka University Medical Center | Cerebral Palsy | 02/09 | 06/09 | | |
NCT00661089: Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity |
|
|
| Completed | N/A | 21 | US | Botulinum Toxin Type A - OnabotulinumtoxinA, BOTOX, Placebo (Saline) | Shirley Ryan AbilityLab, Allergan | Post-stroke Shoulder Pain and Spasticity | 03/09 | 02/10 | | |
NCT00822523: Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies |
|
|
| Completed | N/A | 13 | US | Botulinum Toxin, Type A, BOTOX, Saline, Placebo | Loma Linda University, Allergan | Muscle Strength, Botulinum Toxins, Type A | 03/09 | 07/15 | | |
NCT00503620: The Effect of Botox on Children With Cerebral Palsy |
|
|
| Completed | N/A | 11 | US | Botulinum Toxin A | Shriners Hospitals for Children, United Cerebral Palsy Foundation | Cerebral Palsy | | 06/09 | | |
NCT00564707: Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome |
|
|
| Unknown status | N/A | 84 | US | Biofeedback therapy, Botulinum Toxin Type A Injection | Walter Reed Army Medical Center | Levator Ani Syndrome With Pain and/or Constipation Symptoms. | | 08/09 | | |
NCT01129583: Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness |
|
|
| Completed | N/A | 18 | US | Botulinum Toxin Type A, Botox®, Saline | Columbia University, Allergan | Post Traumatic Stiffness | 09/09 | 05/10 | | |
| Completed | N/A | | US | | Veterans Medical Research Foundation, Allergan | Urinary Incontinence, Urinary Bladder, Overactive | 09/09 | 09/09 | | |
NCT00408798: Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin |
|
|
| Completed | N/A | 20 | Canada | Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units | University of British Columbia | Alopecia Areata | 10/09 | 10/09 | | |
NCT00845897: Botulinum Toxin Effects on Plantar Ulcer Recurrence |
|
|
| Completed | N/A | 17 | US | Botulinum Toxin, botox, Saline | Washington University School of Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Diabetes Mellitus, Peripheral Neuropathy, Plantar Ulcers | 03/10 | 03/10 | | |
| Terminated | N/A | 35 | US | Botulinum Toxin Type A, BOTOX | HealthPartners Institute, Allergan | Migraine Headache | 04/10 | 04/10 | | |
NCT01042119: Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females |
|
|
| Completed | N/A | 200 | Europe | | University of Zurich | Overactive Bladder Syndrome | 06/10 | 06/10 | | |
NCT01332474: JCP Study of Investigation of Patient Background Characteristics |
|
|
| Completed | N/A | 326 | NA | BOTOX | GlaxoSmithKline | Spasticity, Post-Stroke | 08/10 | 08/10 | | |
NCT00345332: A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence |
|
|
| Completed | N/A | 31 | US | Botox, Placebo | University of Rochester | Urinary Incontinence | 05/11 | 05/11 | | |
| Completed | N/A | 25 | Europe | | University Of Perugia, Allergan | Overactive Detrusor, Detrusor Hyperreflexia of Bladder | 06/11 | 03/12 | | |
NCT01608659: An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A |
|
|
| Completed | N/A | 110 | RoW | botulinum toxin Type A, BOTOX®, Xeomin® | Allergan | Facial Rhytides | 06/11 | 06/11 | | |
NCT01391299: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines |
|
|
| Completed | N/A | 175 | Canada | botulinum toxin Type A, BOTOX® Cosmetic, Normal Saline | Allergan | Facial Rhytides, Glabellar Frown Lines | 10/11 | 02/12 | | |
NCT01274611: Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis) |
|
|
| Completed | N/A | 20 | US | Botulinum Toxin Type A, botox, Suction-Curettage, liposuction | Northwestern University | Axillary Hyperhidrosis | 12/11 | 12/11 | | |
NCT02043145: Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea |
|
|
| Completed | N/A | 727 | RoW | botulinum toxin Type A | Allergan | Hyperhidrosis, Muscle Spasticity, Glabellar Lines | 04/12 | 04/12 | | |
| Terminated | N/A | 20 | US | onabotulinumtoxinA, Botox, Bacteriostatic normal saline, Saline | DeNova Research, Allergan | Herpes Labialis | 05/12 | 06/12 | | |
NCT01412008: Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle |
|
|
| Completed | N/A | 5 | US | Botox (botulinum toxin) | New York Presbyterian Hospital | Stroke, Muscle Spasticity | 06/12 | 06/12 | | |
NCT01765309: A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders |
|
|
| Completed | N/A | 23 | US | Bilateral mastectomy with reconstruction, Botulinum toxin (botox) injection | University of Colorado, Denver | Breast Cancer | 07/12 | 07/12 | | |
NCT02122536: Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles |
|
|
| Completed | N/A | 45 | US | Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects, incobotulinumtoxinA (Xeomin), Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects, onabotulinumtoxinA (Botox) | YMD Eye and Face | Facial Wrinkles | 11/12 | 11/13 | | |
NCT00999869: The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata |
|
|
| Unknown status | N/A | 20 | RoW | Botulinum toxin type A, Botox( Allergan Inc.), Triamcinolone acetonide, Kenacort | Siriraj Hospital | Alopecia Areata | 12/12 | 02/13 | | |
NCT03063827: Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients |
|
|
| Completed | N/A | 36 | NA | OnabotulinumtoxinA 200 UNT, OnabotulinumtoxinA (Botox) 200 UNT, Urothelial sensory protein levels, Sensory proteins | Buddhist Tzu Chi General Hospital | Neurogenic Bladder | 12/12 | 12/12 | | |
NCT01608672: Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX® |
|
|
| Completed | N/A | 207 | Canada, US, Europe, RoW | botulinum toxin Type A, BOTOX®, OnabotulinumtoxinA, BOTOX® Cosmetic, Vistabel® | Allergan | Glabellar Lines | 12/12 | 12/12 | | |
NCT01387074: Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity |
|
|
| Completed | N/A | 108 | Europe | botulinum toxin Type A, BOTOX® | Allergan | Muscle Spasticity | 01/13 | 01/13 | | |
NCT01686061: Blepharospasm Patient Survey for Patients With Blepharospasm |
|
|
| Completed | N/A | 124 | US | No intervention- only one time survey | Merz Pharmaceuticals GmbH, Merz North America, Inc. | Blepharospasm | 04/13 | 04/13 | | |
QUALVESTO, NCT02858375: Long-Term Assessment of Quality of Life and Effectiveness of Onabotulinumtoxina Injections in Provoked Vestibulodynia |
|
|
| Completed | N/A | 21 | Europe | | Centre Hospitalier Universitaire de Besancon | Vestibulodynia | 04/13 | 04/13 | | |
UECP, NCT00250081: Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy |
|
|
| Terminated | N/A | 38 | US | Upper Extremity Tendon transfer, Botulinum Toxin injections in Upper Extremity, Regularly ongoing therapy | Shriners Hospitals for Children | Cerebral Palsy | 05/13 | 05/13 | | |
NCT00895063: Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia |
|
|
| Terminated | N/A | 8 | US | Vocal Exercise, Botulinum toxin, BOTOX, BTX, BoNT | NYU Langone Health, Allergan | Spasmodic Dysphonia, Dystonia | 05/13 | 05/13 | | |
NCT01814774: A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm |
|
|
| Completed | N/A | 48 | Europe | No Intervention | Allergan | Cervical Dystonia, Blepharospasm | 07/13 | 07/13 | | |
NCT00836017: CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy |
|
|
| Completed | N/A | 1046 | US | No Intervention | Allergan | Cervical Dystonia | 08/13 | 08/13 | | |
| Completed | N/A | 1372 | Canada | botulinum toxin type A | Allergan | Blepharospasm, Torticollis, Strabismus, Muscle Spasticity | 09/13 | 09/13 | | |
| Completed | N/A | 74 | NA | Botox 200 UNT Injection | University of Gaziantep | Neurogenic Bladder Disorder | 09/23 | 06/24 | | |
NCT01432782: Botulinum Toxin Injection to Treat Diffuse Esophageal Spasm |
|
|
| Unknown status | N/A | 30 | Europe | Placebo, Botulinum Toxin Type A, Botox | Universitaire Ziekenhuizen Leuven | Esophageal Spasm, Diffuse | 12/13 | 12/13 | | |
NCT01749423: A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines |
|
|
| Withdrawn | N/A | 0 | US | OnabotulinumtoxinA, botulinum toxin Type A, BOTOX® | Allergan | Chronic Migraine, Headache | 12/13 | 12/13 | | |
| Completed | N/A | 32 | RoW | Botox, Clostridium Botulinum type A neurotoxin complex | Abdel-Maguid Ramzy | Vaginismus | 03/14 | 03/14 | | |
NCT01483209: Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A |
|
|
| Terminated | N/A | 2 | US | Injection of botulinum toxin A, Botox | Duke University | Ischemia, Vasopressor | 04/14 | 04/14 | | |
NCT01749410: A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines |
|
|
| Completed | N/A | 33 | US | onabotulinumtoxinA, Botulinum Toxin Type A, BOTOX® | Allergan | Chronic Migraine, Headaches | 05/14 | 05/14 | | |
NCT01056861: Effects of Botulinum Toxin in Cervical Dystonia |
|
|
| Completed | N/A | 7 | US | Botulinum Toxin A, Botox, Botulinum toxin A | Henry Ford Health System, Allergan | Torticollis, Cervical Dystonia | 07/14 | 07/14 | | |
NCT01829087: Botulinum Toxin A to Treat Flexion Contracture After Total Knee Arthroplasty |
|
|
| Unknown status | N/A | 140 | US | Botox, placebo | Rothman Institute Orthopaedics, Sharpe-Strumia Research Foundation | Flexion Contracture Following Total Knee Replacement | 08/14 | | | |
NCT01390922: Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.) |
|
|
| Completed | N/A | 1038 | Japan | Botulinum Toxin Type A | GlaxoSmithKline | Mumps | 10/14 | 10/14 | | |
NCT01691651: Botulinum Toxin A for the Treatment of Keratoconus |
|
|
| Completed | N/A | 40 | RoW | Subcutaneous injection of botulinum toxin type A, Botulinum Toxin Type A, Botox (Allergan) | Federal University of São Paulo | Keratoconus | 10/14 | 10/14 | | |
| Completed | N/A | 103 | Europe | Botulinum toxin type A (Botox®, Allergan), Botox®, Allergan, NDC 0023-1145-01, Active strength training and stretching, Eccentric strength training | Seinajoki Central Hospital | Epicondylitis, Lateral Humeral, Tennis Elbow | 12/14 | 12/14 | | |
| Completed | N/A | 5 | Canada | Botulinum toxin A, Botox | University of British Columbia | HIV Posterior Cheek Enlargement | 01/15 | 01/15 | | |
NCT01803464: Effect of Botox and Vibration on Bone in Children With Cerebral Palsy |
|
|
| Completed | N/A | 29 | US | Low-magnitude vibration, Botox | University of Delaware, Alfred I. duPont Hospital for Children, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Cerebral Palsy, Muscle Spasticity | 02/15 | 02/15 | | |
NCT01976611: Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea |
|
|
| Completed | N/A | 402 | RoW | botulinum toxin Type A | Allergan | Migraine Disorders, Headache | 02/15 | 02/15 | | |
NCT01432379: BOTOX® Prophylaxis in Patients With Chronic Migraine |
|
|
| Completed | N/A | 1168 | Europe | botulinum toxin Type A, BOTOX® | Allergan | Migraine Disorders | 05/15 | 05/15 | | |
NCT03385161: Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia |
|
|
| Completed | N/A | 90 | RoW | Botulinum toxin A, onaBONT/A, botox, onabotulinumtoxinA, Ethanol, dehydrated ethanol | Cairo University | Male, Ultrasonography, Botulinum Toxins, Type A, Injection; Complications, Infection, Prostatic Hyperplasia | 06/15 | 06/17 | | |
NCT01811004: Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis |
|
|
| Completed | N/A | 17 | US | miraDry, Nd:YAG Laser, Botox® | Cynosure, Inc. | Hyperhidrosis | 07/15 | 07/15 | | |
NCT00152347: A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot |
|
|
| Completed | N/A | 36 | Canada | Botox | University of British Columbia | Idiopathic Clubfoot (Talipes Equinovarus) | 09/15 | 09/15 | | |
NCT02072928: Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium |
|
|
| Completed | N/A | 55 | Europe | botulinum toxin Type A, onabotulinumtoxinA, BOTOX® | Allergan | Urinary Incontinence | 09/15 | 09/15 | | |
NCT02245958: A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm |
|
|
| Completed | N/A | 44 | Europe, RoW | No Intervention | Allergan | Cervical Dystonia, Blepharospasm | 12/15 | 12/15 | | |
NCT02417077: Perception of Facial Expression in Subjects With and Without Crow's Feet Lines |
|
|
| Completed | N/A | 393 | US | Photographic Review, BOTOX® Cosmetic | Allergan | Healthy Volunteers | 12/15 | 12/15 | | |
NCT03175263: OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain |
|
|
| Completed | N/A | 57 | NA | | University Hospital, Limoges | Chronic Migraine | 12/15 | 12/15 | | |
NCT02161159: An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder |
|
|
| Completed | N/A | 515 | Europe | botulinum toxin Type A, BOTOX®, onabotulinumtoxinA | Allergan | Urinary Incontinence, Urinary Bladder, Overactive | 01/16 | 01/16 | | |
NCT00152334: Efficacy of Botox in Patients With Idiopathic Clubfoot |
|
|
| Completed | N/A | 500 | Canada | Botox | University of British Columbia | Idiopathic Clubfoot (Talipes Equinovarus) | 03/16 | 10/18 | | |
NCT02051933: The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon Fractures |
|
|
| Terminated | N/A | 10 | US | Botulinum toxin type A, Botox, sodium chloride, Normal Saline | Wake Forest University Health Sciences | Equinus Contracture | 03/16 | 05/16 | | |
NCT02010788: Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea |
|
|
| Completed | N/A | 523 | RoW | botulinum toxin Type A, BOTOX®, onabotulinumtoxinA | Allergan | Urinary Incontinence, Urinary Bladder, Overactive | 07/16 | 07/16 | | |
NCT02557971: Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder |
|
|
| Completed | N/A | 315 | US | onabotulinumtoxinA, BOTOX®, botulinum toxin Type A | Allergan | Urinary Bladder, Overactive | 07/16 | 07/16 | | |
NCT03664375: Impact Of Physiotherapy And Botox In Improving Functional Outcomes Among Post Stroke Focal Dystonia Patients |
|
|
| Completed | N/A | 39 | NA | Botulinum toxin type A, Task Specific Training | Isra University | Focal Hand Dystonia | 08/16 | 12/16 | | |
BOREAL, NCT02673047: Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder |
|
|
| Completed | N/A | 474 | Europe | botulinum toxin Type A, Botox®, onabotulinumtoxinA | Allergan | Urinary Bladder, Overactive, Urinary Bladder, Neurogenic | 08/16 | 08/16 | | |
NCT02953015: Non-pharmacological Management of Chronic Migraine |
|
|
| Unknown status | N/A | 16 | Europe | Manipulative articulatory (ART) and myofascial techniques, Manipulations, Transcutaneous Electrical Nerve Stimulation, Electrical stimulations, OnabotulinumtoxinA (Prophylaxis therapy), OnabotulinumtoxinA injections | Universita di Verona, Marialuisa Gandolfi | Headache | 09/16 | 12/17 | | |
NCT02711995: Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation |
|
|
| Completed | N/A | 8 | US | RenuGel, generic: Carboxymethylcellulose, Botulinum Toxin, Botox | Weill Medical College of Cornell University | Essential Tremor | 09/16 | 09/16 | | |
NCT01686581: An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine |
|
|
| Completed | N/A | 641 | Europe, RoW | botulinum toxin Type A, BOTOX®, onabotulinumtoxin A | Allergan | Migraine Disorders | 10/16 | 10/16 | | |
NCT03533062: Trigonal vs Non Trigonal Botox Injection in OAB. |
|
|
| Completed | N/A | 80 | NA | botulinum toxin A, anticholinergics | Mansoura University | Urologic Diseases, Overactive Bladder Syndrome, Quality of Life, Anticholinergic Syndrome | 10/16 | 05/18 | | |
NCT01655862: A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA |
|
|
| Completed | N/A | 62 | Canada | OnabotulinumtoxinA, botulinum toxin Type A, BOTOX® | Allergan | Torticollis | 02/17 | 02/17 | | |
| Terminated | N/A | 13 | Europe | PRP-L Injection, Botox injection, Type A Botulinum toxin injection, Xeomin®, MERZ, Corticoid injection | Centre Hospitalier Universitaire de Nīmes | Epicondylitis, Lateral Humeral, Tennis Elbow | 05/17 | 05/17 | | |
NCT02590250: A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India |
|
|
| Completed | N/A | 250 | RoW | botulinum toxin Type A, BOTOX®, onabotulinumtoxinA | Allergan | Urinary Incontinence, Overactive Bladder | 08/17 | 08/17 | | |
NCT02248844: Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea |
|
|
| Completed | N/A | 667 | RoW | Botulinum Toxin Type A, BOTOX®, onabotulinumtoxinA | Allergan | Lateral Canthal Lines, Crow's Feet Lines | 08/17 | 08/17 | | |
| Completed | N/A | 744 | US, Europe, RoW | onabotulinumtoxinA, BOTOX®, botulinum toxin Type A | Allergan | Muscle Spasticity | 10/17 | 10/17 | | |
NCT03234413: Safety on Switching Between Different Botulinum Toxin-A |
|
|
| Completed | N/A | 118 | RoW | Botulinum toxin type A, Botox, Dysport | Nigar Dursun | Cerebral Palsy | 11/17 | 11/17 | | |
| Completed | N/A | 217 | US | Prism, Orthoptic Exercises, Eye Muscle Surgery, Botox Injection, Botulinum toxin injection | Jaeb Center for Health Research, Pediatric Eye Disease Investigator Group, National Eye Institute (NEI) | Convergence Insufficiency, Divergence Insufficiency, Hypertropia | 12/17 | 01/19 | | |
NCT01905137: Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain |
|
|
| Unknown status | N/A | 64 | US | Intervention-Botulinum Toxin Type A, Botox, placebo, saline | Boston Urogynecology Associates, Allergan | Myofascial Pelvic Pain | 03/18 | 06/19 | | |
NCT02369068: Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain |
|
|
| Completed | N/A | 21 | US | Onabotulinumtoxin A, Botox, Kenalog, triamcinolone | Jamie Bartley, DO | Pelvic Pain | 03/18 | 09/18 | | |
| Completed | N/A | 6 | Canada | Pre-Operative CISS-MRI Sequences, Pre-Operative Interictal Laryngoscopy, Pre-Operative Unilateral and Contralateral Botox, Injections spaced 3-months apart | University of British Columbia | HELPS Syndrome | 04/18 | 10/18 | | |
NCT03349086: Effects of Vocal Exercises for Spasmodic Dysphonia |
|
|
| Completed | N/A | 15 | US | Voice Exercise | University of Wisconsin, Madison | Adductor Spasmodic Dysphonia | 07/18 | 07/18 | | |
ChiCTR-INR-17012013: Clinical study of botulinum toxin type A in the treatment of depressive symptoms in patients with Parkinson's disease |
|
|
| Not yet recruiting | N/A | 80 | | BOTOX Allergan ;0.9% Sodium Chloride Injection | Shanghai Tongji Hospital, Tongji University; Shanghai Tongji Hospital, Tongji University, Research project | Parkinson‘s disease, Depression | | | | |
NCT03344952: Improvement on GMFCS Level of Patients With Cerebral Palsy Treated by Repeated Botulinum Toxin-A |
|
|
| Completed | N/A | 503 | RoW | Botulinum toxin type A, Botox, Dysport, Physical therapy | Kocaeli University | Cerebral Palsy | 10/18 | 11/18 | | |
| Terminated | N/A | 150 | US | OnabotulinumtoxinA (BoNTA), Botox, Percutaneous tibial nerve stimulation (PTNS) | Medstar Health Research Institute, University of Michigan, Methodist Urology Associates, Houston, Texas, Columbia University, University of New Mexico | Overactive Bladder (OAB) | 12/18 | 12/18 | | |
NCT03385460: Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study |
|
|
| Unknown status | N/A | 10 | RoW | ESWL BOTOX | Mansoura University | Overactive Bladder, Botulinum Toxin, Intravesical, ESWL | 01/19 | 01/19 | | |
NCT06966999: Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study |
|
|
| Completed | N/A | 276 | RoW | Botulinum Toxin Type A Injection [Botox] | Second Affiliated Hospital, School of Medicine, Zhejiang University | Acute Acquired Comitant Esotropia | 01/23 | 06/23 | | |
| Completed | N/A | 215 | Canada | No Intervention | Allergan | Migraine Disorders | 01/19 | 01/19 | | |
NCT03407183: The Efficacy of Botulinum Toxin in Spastic Neuropathic Bladder |
|
|
| Unknown status | N/A | 20 | RoW | intradetrusor injection of botulinumtoxinA (Botox) | AHMED FARAHAT HASSAN | Spastic Neurogenic Bladder | 02/19 | 03/19 | | |
NCT03033355: Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder |
|
|
| Completed | N/A | 12 | US | Intra-detrusor injection of Onabotulinumtoxin-A, OnabotulinumtoxinA, Botox® | The Methodist Hospital Research Institute, The Methodist Hospital Research Institute | Multiple Sclerosis, Lower Urinary Tract Symptoms, Neurogenic Bladder, Detrusor, Overactive, Urge Incontinence | 03/19 | 03/19 | | |
NCT03874780: Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder |
|
|
| Completed | N/A | 10 | Europe, RoW | Vibe Delivery system | Vensica Therapeutics Ltd. | Overactive Bladder | 03/19 | 03/19 | | |
NCT06881147: Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights |
|
|
| Enrolling by invitation | N/A | 49 | Europe | Multimodal physiotherapy program | IRCCS San Raffaele, Ospedale San Luca, Istituto Auxologico Italiano, Milano | Cervical Dystonia | 01/26 | 01/27 | | |
| Withdrawn | N/A | 0 | US | Botulinum toxin type A | Northwestern University | Gingival Exposure | 04/19 | 04/19 | | |
| Completed | N/A | 56 | Europe | Injection of Onabotulinum toxin | Swiss Paraplegic Centre Nottwil | Neurogenic Bladder, Overactive Detrusor | 04/19 | 07/19 | | |
